abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Investing Cash Flow
$35.39M
TTM · Period ending: · USD

HQL Investing Cash Flow
Latest reported$35.39Mperiod ending
Latest reported$35.39Mperiod ending
HQL TTM Cash from Investing ($8.30M → $35.39M)
TTM investing cash flow
High-resolution chart · PNG
HQL investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 35,388,348 | |
| 25,214,853 | |
| 4,389,313 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 7,150,000 | |
| 14,300,000 | |
| -14,800,000 | |
| -43,900,000 | |
| -46,150,000 | |
| -48,400,000 | |
| -15,050,000 | |
| 18,300,000 | |
| 18,050,000 | |
| 17,800,000 | |
| 18,350,000 | |
| 18,900,000 | |
| 19,350,000 | |
| 19,800,000 | |
| 17,050,000 | |
| 12,200,000 | |
| 11,000,000 | |
| 9,800,000 | |
| 8,000,000 | |
| 8,300,000 |